Cargando…
Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis
Atherosclerosis is the main pathological basis of cardiovascular disease and involves damage to vascular endothelial cells (ECs) that results in endothelial dysfunction (ED). The vascular endothelium is the key to maintaining blood vessel health and homeostasis. ED is a complex pathological process...
Autores principales: | Wu, Xian-Ming, Zhang, Ning, Li, Jiang-Shan, Yang, Zhi-Hong, Huang, Xiao-Lou, Yang, Xiao-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984579/ https://www.ncbi.nlm.nih.gov/pubmed/34981330 http://dx.doi.org/10.1007/s11302-021-09839-x |
Ejemplares similares
-
P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases
por: Strassheim, Derek, et al.
Publicado: (2020) -
Altered Purinergic Receptor Sensitivity in Type 2 Diabetes-Associated Endothelial Dysfunction and Up(4)A-Mediated Vascular Contraction
por: Mahdi, Ali, et al.
Publicado: (2018) -
Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis
por: Qu, Kai, et al.
Publicado: (2022) -
Purinergic Regulation of Endothelial Barrier Function
por: Aslam, Muhammad, et al.
Publicado: (2021) -
Hypoxia induces purinergic receptor signaling to disrupt endothelial barrier function
por: Raghavan, Somasundaram, et al.
Publicado: (2022)